PSB-11

From WikiMD's WELLNESSPEDIA

PSB-11































PSB-11 is a chemical compound that acts as a selective antagonist of the adenosine A3 receptor. It is primarily used in scientific research to study the physiological and pathological roles of the adenosine A3 receptor, which is a member of the adenosine receptor family.

Pharmacology[edit]

PSB-11 is known for its high selectivity and affinity for the adenosine A3 receptor, which is one of the four subtypes of adenosine receptors, the others being A1, A2A, and A2B. The adenosine A3 receptor is involved in a variety of physiological processes, including inflammation, immune response, and cardioprotection.

Mechanism of Action[edit]

As an antagonist, PSB-11 binds to the adenosine A3 receptor and inhibits its activation by endogenous adenosine. This blockade can modulate various signaling pathways, leading to potential therapeutic effects in conditions such as asthma, cancer, and ischemia.

Therapeutic Potential[edit]

Research into PSB-11 and other adenosine A3 receptor antagonists is ongoing, with studies exploring their potential in treating inflammatory diseases, certain types of cancer, and cardiovascular disorders. The ability of PSB-11 to selectively block the A3 receptor without affecting other adenosine receptors makes it a valuable tool in pharmacological research.

Chemical Properties[edit]

PSB-11 is a small molecule with a specific chemical structure that allows it to interact selectively with the adenosine A3 receptor. The precise chemical structure and properties of PSB-11 are crucial for its function as a selective antagonist.

Research Applications[edit]

PSB-11 is widely used in laboratory settings to investigate the role of the adenosine A3 receptor in various biological systems. It is often used in in vitro and in vivo studies to elucidate the receptor's function and to test the effects of receptor blockade in different disease models.

Safety and Toxicology[edit]

As with many research chemicals, the safety profile of PSB-11 is not fully established, and it is primarily used in controlled laboratory environments. Researchers handling PSB-11 should follow appropriate safety protocols to minimize any potential risks.

Also see[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.